Tyler Bussian
Stock Analyst at Brookline Capital
(0.20)
# 4,077
Out of 4,711 analysts
5
Total ratings
25%
Success rate
-25.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tyler Bussian
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Initiates: Buy | $9 | $1.65 | +445.45% | 1 | Oct 14, 2024 | |
| CRVO CervoMed | Initiates: Buy | $63 | $2.23 | +2,725.11% | 1 | Jul 8, 2024 | |
| IMUX Immunic | Initiates: Buy | $10 | $1.00 | +900.00% | 1 | Apr 5, 2024 | |
| ANVS Annovis Bio | Downgrades: Hold | $9 | $4.37 | +105.95% | 2 | Feb 28, 2024 |
Envoy Medical
Oct 14, 2024
Initiates: Buy
Price Target: $9
Current: $1.65
Upside: +445.45%
CervoMed
Jul 8, 2024
Initiates: Buy
Price Target: $63
Current: $2.23
Upside: +2,725.11%
Immunic
Apr 5, 2024
Initiates: Buy
Price Target: $10
Current: $1.00
Upside: +900.00%
Annovis Bio
Feb 28, 2024
Downgrades: Hold
Price Target: $9
Current: $4.37
Upside: +105.95%